Publications

Publications

300 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Period from
to

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Sort by: Date / Relevance

GVS assessment of 13-valent pneumococcal conjugate vaccine (Prevenar13®) for medical high-risk groups

Zorginstituut Nederland has completed its assessment whether 13-valent pneumococcal conjugate vaccine (PVC13; Prevenar13®) is ...

Report | 03-03-2021

GVS assessment of Brimonidine Stulln 2mg/ml eye drop solution for decrease of increased intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension

Zorginstituut Nederland has completed its assessment whether Brimonidine Stulln 2mg/ml eye drop solution, single-use packaging is ...

Report | 24-02-2021

GVS assessment of sodium zirconium cyclosilicate (Lokelma®) for the treatment of hyperkalemia

Zorginstituut Nederland has completed its assessment whether sodium zirconium cyclosilicate (Lokelma®) is interchangeable with a ...

Report | 12-02-2021

Package advice multiple myeloma

Several combination therapies that are used to treat multiple myelomain are placed in the lock procedure for expensive medicinal ...

Report | 11-02-2021

GVS assessment of opicapone (Ongentys®) for the treatment of Parkinson's disease

Zorginstituut Nederland has completed its assessment whether opicapone (Ongentys®) is interchangeable with a product that has ...

Report | 03-02-2021

GVS advice mexiletine (Namuscla®)

Zorginstituut Nederland has completed its assessment whether the product mexiletine (Namuscla®) is interchangeable with another ...

Report | 13-01-2021

GVS advice concerning romosozumab (Evenity®) for the treatment of severe osteoporosis

Zorginstituut Nederland has completed its assessment whether romosozumab (Evenity®) is interchangeable with a product that is ...

Report | 16-12-2020

GVS assessment of amikacin liposome inhalation suspension (Arikayce® liposomal) for the treatment of NTM lung infections

Zorginstituut Nederland has completed its assessment whether amikacin liposome inhalation suspension (Arikayce® liposomal) can be ...

Report | 15-12-2020

GVS assessment - extension of further conditions for nintedanib (Ofev®)

Zorginstituut Nederland has completed its assessment of the possible extension of the further conditions for nintedanib (Ofev®) ...

Report | 15-12-2020

Package advice polatuzumab vedotin (Polivy®) in combination with bendamustine and rituximab (Pola-BR) for the treatment of r/r DLBCL

Zorginstituut Nederland has completed its assessment whether polatuzumab vedotin (Polivy®) in combination with bendamustine and ...

Report | 10-12-2020